Five Oceans Advisors Amgen Inc Transaction History

Five Oceans Advisors

$189 Million
Q3 2024

A detailed history of Five Oceans Advisors transactions in Amgen Inc stock. As of the latest transaction made, Five Oceans Advisors holds 1,321 shares of AMGN stock, worth $369,972. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,321

Previous 1,317 0.3%

Holding current value

$369,972

Previous $411,000 3.41%

% of portfolio

0.22%

Previous 0.24%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $1,237 - $1,349	4 Added 0.3%	1,321 $425,000
Q2 2024 Jul 10, 2024	SELL	$262.75 - $319.31 $46,244 - $56,198	-176 Reduced 11.79%	1,317 $411,000
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $2,419 - $2,921	-9 Reduced 0.6%	1,493 $424,000
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $511 - $576	-2 Reduced 0.13%	1,502 $432,000
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $4,154 - $5,157	19 Added 1.28%	1,504 $404,000
Q2 2023 Jul 14, 2023	BUY	$214.27 - $253.37 $35,568 - $42,059	166 Added 12.59%	1,485 $329,000
Q1 2023 Apr 14, 2023	BUY	$225.79 - $275.2 $37,932 - $46,233	168 Added 14.6%	1,319 $318,000
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $1,374 - $1,746	-6 Reduced 0.52%	1,151 $0
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $14,365 - $16,201	64 Added 5.86%	1,157 $261,000
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $12,689 - $14,120	55 Added 5.3%	1,093 $266,000
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $13,814 - $15,281	63 Added 6.46%	1,038 $251,000
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $4,972 - $5,690	25 Added 2.63%	975 $219,000
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $201,656 - $236,265	950 New	950 $202,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Five Oceans Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Five Oceans Advisors with notifications on news.

Account

Five Oceans Advisors Amgen Inc Transaction History